f

Puerto Rico Pharmaceuticals & Healthcare Report Q4 2013 – New Market Research Report

Puerto Rico Pharmaceuticals & Healthcare Report Q4 2013 – New Market Research Report

Puerto Rico’s importance as a major production hub for multinational pharmaceutical companies will continue to diminish on account of patent expirations, production quality issues, increasing labour and operational costs, and a potential tax increase by the local government. However, the pharmaceutical industry will still be an economic mainstay for the country, as evidenced by the recent investment by US major Bristol-Myers Squibb (BMS). The island’s incentives will continue to attract multinational drugmakers’ investment provided the market’s appeal continues to offset the effect of negative issues.

What do you think?